Zonisamide derivative, homogeneous enzyme immunoassay reagent and preparation method

A technology of homogeneous enzyme immunoassay and zonisamine enzyme is applied in the field of zonisamide derivatives, homogeneous enzyme immunoassay detection reagents and preparation, and can solve the problem of high professional requirements of operators, high price of high-precision instruments, and microscopic latex. It can improve the detection sensitivity, be easy to implement and popularize and use, and achieve the effect of high accuracy.

Pending Publication Date: 2022-05-06
安徽爱索特克医学检验实验室有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

High-performance liquid chromatography has high sensitivity and a wide detection range, but it has defects such as complicated sample processing, high-precision instruments are expensive, require specially trained technicians to operate, and high maintenance costs, making it difficult to be widely promoted in clinical practice
The advantages of ion chromatography-suppressed conductometric detection method are convenience, high sensitivity, and good selectivity, and ion chromatography-suppressed conductometric detection method can mea

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Zonisamide derivative, homogeneous enzyme immunoassay reagent and preparation method
  • Zonisamide derivative, homogeneous enzyme immunoassay reagent and preparation method
  • Zonisamide derivative, homogeneous enzyme immunoassay reagent and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0075] Example 1: Preparation of Zonisamide Derivatives

[0076] The synthetic route of zonisamide derivatives is as follows:

[0077] .

[0078] The preparation method of the zonisamide derivative comprises the following steps:

[0079] Compound 1 (7 g) was weighed and dissolved in toluene (70 ml), and then succinic anhydride (4 g) was added to prepare a reaction mixture solution, which was stirred overnight under reflux conditions. After the reaction, the above reaction mixture solution was concentrated, and then purified by flash chromatography to obtain 4 g of zonisamide derivatives.

[0080] pass 1 H NMR (Varian mercury plus 400 MHz) spectral scanning analysis (TMS as the internal standard) and LC-MS (Agilent 1200A) were used to identify the chemical structures of the obtained zonisamide derivatives. The results showed that the zonisamide derivatives were: That is, the zonisamide derivative whose structural formula is shown in formula (V).

[0081]

[0082] Form...

Example Embodiment

[0083] Example 2: Preparation of zonisamide immunogen

[0084] The preparation method of zonisamide immunogen comprises the following steps:

[0085] (A1) Preparation of carrier solution: Dissolve the carrier protein in 0.2 mol / L potassium phosphate buffer (pH=8.5), and the final concentration of the carrier protein is 5.5 mg / mL to obtain a carrier solution;

[0086] (A2) Preparation of zonisamide derivative solution: 200 mg of the above zonisamide derivative, 4 mL of dimethylformamide, 4 mL of ethanol, 6 mL of potassium phosphate buffer (10 mmol / L, pH=7.0), 200 mg of 1-ethyl-3-(-3-dimethylaminopropyl) carbodiimide and 60 mg of N-hydroxysulfosuccinimide were mixed, and stirred and dissolved for 120 min to obtain a zonisamide derivative solution;

[0087] (A3) Synthesis of zonisamide immunogen: The zonisamide derivative solution obtained in step (A2) was added to the carrier solution obtained in step (A1), and stirred overnight at 4°C, purified by dialysis, Zonisamide immunog...

Example Embodiment

[0088] Example 3: Preparation of anti-zonisamide-specific antibodies

[0089] The preparation method of anti-zonisamide specific antibody comprises the following steps:

[0090] (B1) Dilute the above-mentioned zonisamide immunogen with 0.01mol / L sodium phosphate buffer (pH=6.5) to a final concentration of 2.0mg / mL to obtain an artificial antigen solution, and then mix the artificial antigen solution with an equal amount of Mixed with complete adjuvant, the experimental animals were injected into rabbits at multiple points;

[0091] (B2) After 3 weeks, the same artificial antigen solution and the same amount of incomplete Freund's adjuvant were used to inject the above experimental animal rabbits at multiple points, and then once every 3 weeks, for a total of 5 injections;

[0092] (B3) Blood is drawn from the experimental animal rabbits injected in step (B2), and separated and purified to obtain an anti-zonisamide specific antibody.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a zonisamide derivative, a detection reagent and a preparation method, and relates to the technical field of biological detection. The zonisamide immunogen prepared from the zonisamide derivative is high in immunogenicity, and the obtained antibody is high in specificity and high in titer; a zonisamide enzyme-labeled conjugate in a homogeneous enzyme immunodetection reagent prepared from the derivative is connected with recombinant glucose-6-phosphate dehydrogenase modified by genetic engineering, so that the detection sensitivity is remarkably improved, a sample with the concentration as low as 2.00 g/mL or below can be effectively detected, the specificity is high, and no cross reaction with common 62 other drugs exists; the zonisamide content can be rapidly detected with high flux on a full-automatic biochemical analyzer, the detection result is stable, the accuracy is high, and the detection method is simple and easy to implement, popularize and use.

Description

technical field [0001] The invention relates to the technical field of biological detection, in particular to a zonisamide derivative, a homogeneous enzyme immunoassay reagent and a preparation method. Background technique [0002] Zonisamide (Zonisamide, ZNS) is a new type of antiepileptic drugs (antiepileptic drugs, AEDs), its chemical name is 1,2-benzisoxazole-3-methanesulfonamide, its molecular weight is 212.23, and its molecular formula is C 8 h 8 N 2 o 3 S, its chemical structural formula is shown in formula (IV): [0003] [0004] Formula (Ⅳ). [0005] Zonisamide exerts its effect mainly through three mechanisms: (1) altering the voltage-dependent ion channels related to action potential propagation or burst firing; (2) enhancing GABA-mediated inhibition; (3) interfering with amino acid-mediated Guided excitability. Main clinical applications: treatment of simple and complex partial seizures and secondary generalized tonic-clonic seizures, partial and general...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D261/20G01N33/535
CPCC07D261/20G01N33/94G01N33/535
Inventor 余琳赵玉冰李冬蔡江丽
Owner 安徽爱索特克医学检验实验室有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap